HS Diagnomics GmbH
Industry / private company
Location:
Berlin,
Germany (DE)
Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL (2022)
Cobo MFL, Ritter J, Gary R, Seitz V, Mautner J, Aigner M, Völkl S, et al.
Journal article
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer—findings from the RIBECCA trial (2022)
Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, Gjerga E, Hennig S, Schaper S, et al.
Journal article